1. Home
  2. GKOS vs NXST Comparison

GKOS vs NXST Comparison

Compare GKOS & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • NXST
  • Stock Information
  • Founded
  • GKOS 1998
  • NXST 1996
  • Country
  • GKOS United States
  • NXST United States
  • Employees
  • GKOS N/A
  • NXST N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • NXST Broadcasting
  • Sector
  • GKOS Health Care
  • NXST Industrials
  • Exchange
  • GKOS Nasdaq
  • NXST Nasdaq
  • Market Cap
  • GKOS 5.4B
  • NXST 6.3B
  • IPO Year
  • GKOS 2015
  • NXST 2003
  • Fundamental
  • Price
  • GKOS $82.38
  • NXST $202.95
  • Analyst Decision
  • GKOS Strong Buy
  • NXST Strong Buy
  • Analyst Count
  • GKOS 12
  • NXST 7
  • Target Price
  • GKOS $128.58
  • NXST $221.43
  • AVG Volume (30 Days)
  • GKOS 698.2K
  • NXST 370.3K
  • Earning Date
  • GKOS 11-03-2025
  • NXST 11-06-2025
  • Dividend Yield
  • GKOS N/A
  • NXST 3.67%
  • EPS Growth
  • GKOS N/A
  • NXST 53.49
  • EPS
  • GKOS N/A
  • NXST 19.36
  • Revenue
  • GKOS $432,953,000.00
  • NXST $5,316,000,000.00
  • Revenue This Year
  • GKOS $28.79
  • NXST N/A
  • Revenue Next Year
  • GKOS $25.65
  • NXST $10.28
  • P/E Ratio
  • GKOS N/A
  • NXST $10.48
  • Revenue Growth
  • GKOS 26.70
  • NXST 6.55
  • 52 Week Low
  • GKOS $77.10
  • NXST $141.66
  • 52 Week High
  • GKOS $163.71
  • NXST $223.36
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 35.40
  • NXST 51.83
  • Support Level
  • GKOS $80.52
  • NXST N/A
  • Resistance Level
  • GKOS $95.32
  • NXST $208.95
  • Average True Range (ATR)
  • GKOS 2.82
  • NXST 4.88
  • MACD
  • GKOS -1.23
  • NXST -8.42
  • Stochastic Oscillator
  • GKOS 11.29
  • NXST 96.43

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

Share on Social Networks: